APO Research
Talk to an analyst

APO RESEARCH · REPORT

Tafenoquine

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Tafenoquine Industry Growth and Trends Forecast to 2032

2 January 202692 pages

Choose your research edition.

Industry ResearchTafenoquine Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Tafenoquine Industry Growth and Trends Forecast to 203292 pages · $3,450 USDMarket StructureGlobal Tafenoquine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Tafenoquine Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Tafenoquine Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Tafenoquine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Tafenoquine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Tafenoquine is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Tafenoquine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Tafenoquine include Pharmacodia (Beijing) Co.,Ltd, Merck, GlaxoSmithKline Pharmaceuticals (GSK), WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd., J & K Scientific LTD, BOC Sciences and Amadis Chemical Company Limited, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Tafenoquine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Tafenoquine market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Tafenoquine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Tafenoquine.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Tafenoquine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Tafenoquine Market by Company

Pharmacodia (Beijing) Co.,Ltd

Merck

GlaxoSmithKline Pharmaceuticals (GSK)

WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd.

J & K Scientific LTD

BOC Sciences

Amadis Chemical Company Limited

Tafenoquine Segment by Type

Powder

Pills

Tafenoquine Segment by Application

P. falciparum Treatment

Radical Cure of P.vivax

Prevention of Malaria Relapse

Tafenoquine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tafenoquine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Tafenoquine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tafenoquine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Tafenoquine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Tafenoquine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Powder Table 2. Major Company of Pills Table 3. Global Tafenoquine Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Tafenoquine Sales by Type (2021-2026) & (K Units) Table 5. Global Tafenoquine Sales Market Share in Volume by Type (2021-2026) Table 6. Global Tafenoquine Sales by Type (2021-2026) & (US$ Million) Table 7. Global Tafenoquine Sales Market Share in Value by Type (2021-2026) Table 8. Global Tafenoquine Price by Type (2021-2026) & (US$/Unit) Table 9. Global Tafenoquine Sales by Type (2027-2032) & (K Units) Table 10. Global Tafenoquine Sales Market Share in Volume by Type (2027-2032) Table 11. Global Tafenoquine Sales by Type (2027-2032) & (US$ Million) Table 12. Global Tafenoquine Sales Market Share in Value by Type (2027-2032) Table 13. Global Tafenoquine Price by Type (2027-2032) & (US$/Unit) Table 14. North America Tafenoquine Sales by Type (2021-2026) & (K Units) Table 15. North America Tafenoquine Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Tafenoquine Sales by Type (2021-2026) & (K Units) Table 17. Europe Tafenoquine Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Tafenoquine Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Tafenoquine Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Tafenoquine Sales by Type (2021-2026) & (K Units) Table 21. Latin America Tafenoquine Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Tafenoquine Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Tafenoquine Sales by Type (2021-2026) & (US$ Million) Table 24. Tafenoquine Industry Trends Table 25. Tafenoquine Industry Drivers Table 26. Tafenoquine Industry Opportunities and Challenges Table 27. Tafenoquine Industry Restraints Table 28. Global Tafenoquine Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Tafenoquine Revenue Market Share by Company (2021-2026) Table 30. Global Tafenoquine Sales by Company (2021-2026) & (K Units) Table 31. Global Tafenoquine Sales Share by Company (2021-2026) Table 32. Global Tafenoquine Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Tafenoquine Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Tafenoquine Major Company Production Sites and Headquarters Table 35. Global Tafenoquine Company, Product Type & Application Table 36. Global Tafenoquine Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Tafenoquine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Tafenoquine Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Tafenoquine Sales by Region (2021-2026) & (K Units) Table 41. Global Tafenoquine Sales Market Share in Volume by Region (2021-2026) Table 42. Global Tafenoquine Sales by Region (2021-2026) & (US$ Million) Table 43. Global Tafenoquine Sales Market Share in Value by Region (2021-2026) Table 44. Global Tafenoquine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Tafenoquine Sales by Region (2027-2032) & (K Units) Table 46. Global Tafenoquine Sales Market Share in Volume by Region (2027-2032) Table 47. Global Tafenoquine Sales by Region (2027-2032) & (US$ Million) Table 48. Global Tafenoquine Sales Market Share in Value by Region (2027-2032) Table 49. Global Tafenoquine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Tafenoquine Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Tafenoquine Sales by Application (2021-2026) & (K Units) Table 52. Global Tafenoquine Sales Market Share in Volume by Application (2021-2026) Table 53. Global Tafenoquine Sales by Application (2021-2026) & (US$ Million) Table 54. Global Tafenoquine Sales Market Share in Value by Application (2021-2026) Table 55. Global Tafenoquine Price by Application (2021-2026) & (US$/Unit) Table 56. Global Tafenoquine Sales by Application (2027-2032) & (K Units) Table 57. Global Tafenoquine Sales Market Share in Volume by Application (2027-2032) Table 58. Global Tafenoquine Sales by Application (2027-2032) & (US$ Million) Table 59. Global Tafenoquine Sales Market Share in Value by Application (2027-2032) Table 60. Global Tafenoquine Price by Application (2027-2032) & (US$/Unit) Table 61. North America Tafenoquine Sales by Application (2021-2026) & (K Units) Table 62. North America Tafenoquine Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Tafenoquine Sales by Application (2021-2026) & (K Units) Table 64. Europe Tafenoquine Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Tafenoquine Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Tafenoquine Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Tafenoquine Sales by Application (2021-2026) & (K Units) Table 68. Latin America Tafenoquine Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Tafenoquine Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Tafenoquine Sales by Application (2021-2026) & (US$ Million) Table 71. Pharmacodia (Beijing) Co.,Ltd Company Information Table 72. Pharmacodia (Beijing) Co.,Ltd Business Overview Table 73. Pharmacodia (Beijing) Co.,Ltd Tafenoquine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Pharmacodia (Beijing) Co.,Ltd Tafenoquine Product Portfolio Table 75. Pharmacodia (Beijing) Co.,Ltd Recent Development Table 76. Merck Company Information Table 77. Merck Business Overview Table 78. Merck Tafenoquine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Merck Tafenoquine Product Portfolio Table 80. Merck Recent Development Table 81. GlaxoSmithKline Pharmaceuticals (GSK) Company Information Table 82. GlaxoSmithKline Pharmaceuticals (GSK) Business Overview Table 83. GlaxoSmithKline Pharmaceuticals (GSK) Tafenoquine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. GlaxoSmithKline Pharmaceuticals (GSK) Tafenoquine Product Portfolio Table 85. GlaxoSmithKline Pharmaceuticals (GSK) Recent Development Table 86. WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Company Information Table 87. WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Business Overview Table 88. WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Tafenoquine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Tafenoquine Product Portfolio Table 90. WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Recent Development Table 91. J & K Scientific LTD Company Information Table 92. J & K Scientific LTD Business Overview Table 93. J & K Scientific LTD Tafenoquine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. J & K Scientific LTD Tafenoquine Product Portfolio Table 95. J & K Scientific LTD Recent Development Table 96. BOC Sciences Company Information Table 97. BOC Sciences Business Overview Table 98. BOC Sciences Tafenoquine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. BOC Sciences Tafenoquine Product Portfolio Table 100. BOC Sciences Recent Development Table 101. Amadis Chemical Company Limited Company Information Table 102. Amadis Chemical Company Limited Business Overview Table 103. Amadis Chemical Company Limited Tafenoquine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Amadis Chemical Company Limited Tafenoquine Product Portfolio Table 105. Amadis Chemical Company Limited Recent Development Table 106. North America Tafenoquine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 107. North America Tafenoquine Sales by Country (2021-2026) & (K Units) Table 108. North America Tafenoquine Sales Market Share by Country (2021-2026) Table 109. North America Tafenoquine Sales Forecast by Country (2027-2032) & (K Units) Table 110. North America Tafenoquine Sales Market Share Forecast by Country (2027-2032) Table 111. North America Tafenoquine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 112. North America Tafenoquine Market Size by Country (2021-2026) & (US$ Million) Table 113. North America Tafenoquine Market Share by Country (2021-2026) Table 114. North America Tafenoquine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 115. North America Tafenoquine Market Share Forecast by Country (2027-2032) Table 116. Europe Tafenoquine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 117. Europe Tafenoquine Sales by Country (2021-2026) & (K Units) Table 118. Europe Tafenoquine Sales Market Share by Country (2021-2026) Table 119. Europe Tafenoquine Sales Forecast by Country (2027-2032) & (K Units) Table 120. Europe Tafenoquine Sales Market Share Forecast by Country (2027-2032) Table 121. Europe Tafenoquine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 122. Europe Tafenoquine Market Size by Country (2021-2026) & (US$ Million) Table 123. Europe Tafenoquine Market Share by Country (2021-2026) Table 124. Europe Tafenoquine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 125. Europe Tafenoquine Market Share Forecast by Country (2027-2032) Table 126. Asia-Pacific Tafenoquine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 127. Asia-Pacific Tafenoquine Sales by Country (2021-2026) & (K Units) Table 128. Asia-Pacific Tafenoquine Sales Market Share by Country (2021-2026) Table 129. Asia-Pacific Tafenoquine Sales Forecast by Country (2027-2032) & (K Units) Table 130. Asia-Pacific Tafenoquine Sales Market Share Forecast by Country (2027-2032) Table 131. Asia-Pacific Tafenoquine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. Asia-Pacific Tafenoquine Market Size by Country (2021-2026) & (US$ Million) Table 133. Asia-Pacific Tafenoquine Market Share by Country (2021-2026) Table 134. Asia-Pacific Tafenoquine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. Asia-Pacific Tafenoquine Market Share Forecast by Country (2027-2032) Table 136. Latin America Tafenoquine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 137. Latin America Tafenoquine Sales by Country (2021-2026) & (K Units) Table 138. Latin America Tafenoquine Sales Market Share by Country (2021-2026) Table 139. Latin America Tafenoquine Sales Forecast by Country (2027-2032) & (K Units) Table 140. Latin America Tafenoquine Sales Market Share Forecast by Country (2027-2032) Table 141. Latin America Tafenoquine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. Latin America Tafenoquine Market Size by Country (2021-2026) & (US$ Million) Table 143. Latin America Tafenoquine Market Share by Country (2021-2026) Table 144. Latin America Tafenoquine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. Latin America Tafenoquine Market Share Forecast by Country (2027-2032) Table 146. Middle East and Africa Tafenoquine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 147. Middle East and Africa Tafenoquine Sales by Country (2021-2026) & (K Units) Table 148. Middle East and Africa Tafenoquine Sales Market Share by Country (2021-2026) Table 149. Middle East and Africa Tafenoquine Sales Forecast by Country (2027-2032) & (K Units) Table 150. Middle East and Africa Tafenoquine Sales Market Share Forecast by Country (2027-2032) Table 151. Middle East and Africa Tafenoquine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Middle East and Africa Tafenoquine Market Size by Country (2021-2026) & (US$ Million) Table 153. Middle East and Africa Tafenoquine Market Share by Country (2021-2026) Table 154. Middle East and Africa Tafenoquine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Middle East and Africa Tafenoquine Market Share Forecast by Country (2027-2032) Table 156. Key Raw Materials Table 157. Raw Materials Key Suppliers Table 158. Tafenoquine Distributors List Table 159. Tafenoquine Customers List Table 160. Research Programs/Design for This Report Table 161. Authors List of This Report Table 162. Secondary Sources Table 163. Primary Sources List of Figures Figure 1. Tafenoquine Image Figure 2. Global Tafenoquine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Tafenoquine Market Size (2021-2032) & (US$ Million) Figure 4. Global Tafenoquine Sales (2021-2032) & (K Units) Figure 5. Powder Image Figure 6. Global Powder Sales YoY Growth (2021-2032) & (K Units) Figure 7. Pills Image Figure 8. Global Pills Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Tafenoquine Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Tafenoquine Market Share by Type 2025 VS 2032 Figure 11. North America Tafenoquine Sales Market Share in Volume by Type in 2025 Figure 12. North America Tafenoquine Sales Market Share in Value by Type in 2025 Figure 13. Europe Tafenoquine Sales Market Share in Volume by Type in 2025 Figure 14. Europe Tafenoquine Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Tafenoquine Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Tafenoquine Sales Market Share in Value by Type in 2025 Figure 17. Latin America Tafenoquine Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Tafenoquine Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Tafenoquine Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Tafenoquine Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Tafenoquine Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. P. falciparum Treatment Image Figure 24. Global P. falciparum Treatment Sales YoY Growth (2021-2032) & (K Units) Figure 25. Radical Cure of P.vivax Image Figure 26. Global Radical Cure of P.vivax Sales YoY Growth (2021-2032) & (K Units) Figure 27. Prevention of Malaria Relapse Image Figure 28. Global Prevention of Malaria Relapse Sales YoY Growth (2021-2032) & (K Units) Figure 29. Global Tafenoquine Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Tafenoquine Market Share by Application 2025 VS 2032 Figure 31. North America Tafenoquine Sales Market Share in Volume by Application in 2025 Figure 32. North America Tafenoquine Sales Market Share in Value by Application in 2025 Figure 33. Europe Tafenoquine Sales Market Share in Volume by Application in 2025 Figure 34. Europe Tafenoquine Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Tafenoquine Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Tafenoquine Sales Market Share in Value by Application in 2025 Figure 37. Latin America Tafenoquine Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Tafenoquine Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Tafenoquine Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Tafenoquine Sales Market Share in Value by Application in 2025 Figure 41. North America Tafenoquine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 42. North America Tafenoquine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Tafenoquine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Tafenoquine Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Tafenoquine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. Europe Tafenoquine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Tafenoquine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Tafenoquine Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Tafenoquine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Asia-Pacific Tafenoquine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Tafenoquine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Tafenoquine Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Tafenoquine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Latin America Tafenoquine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Tafenoquine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Tafenoquine Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Tafenoquine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Middle East and Africa Tafenoquine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Tafenoquine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Tafenoquine Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Tafenoquine Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Tafenoquine Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Powder
  • Pills
Applications
  • P. falciparum Treatment
  • Radical Cure of P.vivax
  • Prevention of Malaria Relapse
Companies covered
  • Pharmacodia (Beijing) Co.,Ltd
  • Merck
  • GlaxoSmithKline Pharmaceuticals (GSK)
  • WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd.
  • J & K Scientific LTD
  • BOC Sciences
  • Amadis Chemical Company Limited

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Tafenoquine Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Tafenoquine Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Tafenoquine Market by Type
  6. 1.3.1 Powder
  7. 1.3.2 Pills
  8. 1.4 Global Tafenoquine Market Size by Type
  9. 1.4.1 Global Tafenoquine Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Tafenoquine Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Tafenoquine Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Tafenoquine Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Tafenoquine Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Tafenoquine Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Tafenoquine Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Tafenoquine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Tafenoquine Industry Trends
  2. 2.2 Tafenoquine Industry Drivers
  3. 2.3 Tafenoquine Industry Opportunities and Challenges
  4. 2.4 Tafenoquine Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Tafenoquine Revenue (2021-2026)
  2. 3.2 Global Top Players by Tafenoquine Sales (2021-2026)
  3. 3.3 Global Top Players by Tafenoquine Price (2021-2026)
  4. 3.4 Global Tafenoquine Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Tafenoquine Major Company Production Sites & Headquarters
  6. 3.6 Global Tafenoquine Company, Product Type & Application
  7. 3.7 Global Tafenoquine Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Tafenoquine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Tafenoquine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Tafenoquine Tier 1, Tier 2, and Tier 3
4 Tafenoquine Regional Status and Outlook
  1. 4.1 Global Tafenoquine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Tafenoquine Historic Market Size by Region
  3. 4.2.1 Global Tafenoquine Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Tafenoquine Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Tafenoquine Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Tafenoquine Forecasted Market Size by Region
  7. 4.3.1 Global Tafenoquine Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Tafenoquine Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Tafenoquine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Tafenoquine by Application
  1. 5.1 Tafenoquine Market by Application
  2. 5.1.1 P. falciparum Treatment
  3. 5.1.2 Radical Cure of P.vivax
  4. 5.1.3 Prevention of Malaria Relapse
  5. 5.2 Global Tafenoquine Market Size by Application
  6. 5.2.1 Global Tafenoquine Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Tafenoquine Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Tafenoquine Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Tafenoquine Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Tafenoquine Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Tafenoquine Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Tafenoquine Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Tafenoquine Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Pharmacodia (Beijing) Co.,Ltd
  2. 6.1.1 Pharmacodia (Beijing) Co.,Ltd Company Information
  3. 6.1.2 Pharmacodia (Beijing) Co.,Ltd Business Overview
  4. 6.1.3 Pharmacodia (Beijing) Co.,Ltd Tafenoquine Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Pharmacodia (Beijing) Co.,Ltd Tafenoquine Product Portfolio
  6. 6.1.5 Pharmacodia (Beijing) Co.,Ltd Recent Developments
  7. 6.2 Merck
  8. 6.2.1 Merck Company Information
  9. 6.2.2 Merck Business Overview
  10. 6.2.3 Merck Tafenoquine Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Merck Tafenoquine Product Portfolio
  12. 6.2.5 Merck Recent Developments
  13. 6.3 GlaxoSmithKline Pharmaceuticals (GSK)
  14. 6.3.1 GlaxoSmithKline Pharmaceuticals (GSK) Company Information
  15. 6.3.2 GlaxoSmithKline Pharmaceuticals (GSK) Business Overview
  16. 6.3.3 GlaxoSmithKline Pharmaceuticals (GSK) Tafenoquine Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 GlaxoSmithKline Pharmaceuticals (GSK) Tafenoquine Product Portfolio
  18. 6.3.5 GlaxoSmithKline Pharmaceuticals (GSK) Recent Developments
  19. 6.4 WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd.
  20. 6.4.1 WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Company Information
  21. 6.4.2 WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Business Overview
  22. 6.4.3 WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Tafenoquine Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Tafenoquine Product Portfolio
  24. 6.4.5 WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Recent Developments
  25. 6.5 J & K Scientific LTD
  26. 6.5.1 J & K Scientific LTD Company Information
  27. 6.5.2 J & K Scientific LTD Business Overview
  28. 6.5.3 J & K Scientific LTD Tafenoquine Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 J & K Scientific LTD Tafenoquine Product Portfolio
  30. 6.5.5 J & K Scientific LTD Recent Developments
  31. 6.6 BOC Sciences
  32. 6.6.1 BOC Sciences Company Information
  33. 6.6.2 BOC Sciences Business Overview
  34. 6.6.3 BOC Sciences Tafenoquine Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 BOC Sciences Tafenoquine Product Portfolio
  36. 6.6.5 BOC Sciences Recent Developments
  37. 6.7 Amadis Chemical Company Limited
  38. 6.7.1 Amadis Chemical Company Limited Company Information
  39. 6.7.2 Amadis Chemical Company Limited Business Overview
  40. 6.7.3 Amadis Chemical Company Limited Tafenoquine Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Amadis Chemical Company Limited Tafenoquine Product Portfolio
  42. 6.7.5 Amadis Chemical Company Limited Recent Developments
7 North America by Country
  1. 7.1 North America Tafenoquine Sales by Country
  2. 7.1.1 North America Tafenoquine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Tafenoquine Sales by Country (2021-2026)
  4. 7.1.3 North America Tafenoquine Sales Forecast by Country (2027-2032)
  5. 7.2 North America Tafenoquine Market Size by Country
  6. 7.2.1 North America Tafenoquine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Tafenoquine Market Size by Country (2021-2026)
  8. 7.2.3 North America Tafenoquine Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Tafenoquine Sales by Country
  2. 8.1.1 Europe Tafenoquine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Tafenoquine Sales by Country (2021-2026)
  4. 8.1.3 Europe Tafenoquine Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Tafenoquine Market Size by Country
  6. 8.2.1 Europe Tafenoquine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Tafenoquine Market Size by Country (2021-2026)
  8. 8.2.3 Europe Tafenoquine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Tafenoquine Sales by Country
  2. 9.1.1 Asia-Pacific Tafenoquine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Tafenoquine Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Tafenoquine Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Tafenoquine Market Size by Country
  6. 9.2.1 Asia-Pacific Tafenoquine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Tafenoquine Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Tafenoquine Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Tafenoquine Sales by Country
  2. 10.1.1 South America Tafenoquine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Tafenoquine Sales by Country (2021-2026)
  4. 10.1.3 South America Tafenoquine Sales Forecast by Country (2027-2032)
  5. 10.2 South America Tafenoquine Market Size by Country
  6. 10.2.1 South America Tafenoquine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Tafenoquine Market Size by Country (2021-2026)
  8. 10.2.3 South America Tafenoquine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Tafenoquine Sales by Country
  2. 11.1.1 Middle East and Africa Tafenoquine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Tafenoquine Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Tafenoquine Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Tafenoquine Market Size by Country
  6. 11.2.1 Middle East and Africa Tafenoquine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Tafenoquine Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Tafenoquine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Tafenoquine Value Chain Analysis
  2. 12.1.1 Tafenoquine Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Tafenoquine Production Mode & Process
  7. 12.2 Tafenoquine Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Tafenoquine Distributors
  10. 12.2.3 Tafenoquine Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst